Skip to Main Content

Paper Details

Small-Molecule and CRISPR Screening Converge to Reveal Receptor Tyrosine Kinase Dependencies in Pediatric Rhabdoid Tumors.
Cell Rep
25
2019
Cancer, Cas9, PTPN11, Pediatric, Pediatric Rhabdoid Tumors, RT, RT cell lines, RTK, RTKs, RTs, Receptor Tyrosine Kinase, SHP2, Tyrosine, cancers, chromosomal abnormalities, control cell lines, genomes, receptor tyrosine kinases, rhabdoid tumors, tyrosine, xenograft
Author NameAffiliation
Matthew G ReesBroad Institute
Francisca VazquezBroad Institute
Barbara A WeirBroad Institute
Barbara A WeirBroad Institute
Aviad TsherniakBroad Institute
Aviad TsherniakBroad Institute
Mahmoud GhandiBroad Institute
David E RootBroad Institute
David E RootBroad Institute
Jaime H CheahBroad Institute
Alykhan F ShamjiBroad Institute
Alykhan F ShamjiBroad Institute
Paul A ClemonsBroad Institute
Paul A ClemonsBroad Institute
Peter J ParkHarvard Medical School
Peter J ParkHarvard Medical School
Todd R GolubBroad Institute, Harvard Medical School, Dana-Farber Cancer Institute
Todd R GolubBroad Institute, Harvard Medical School, Dana-Farber Cancer Institute
Kimberly StegmaierDana-Farber Cancer Institute, USA Broad Institute, USA Boston Children's Hospital
Kimberly StegmaierDana-Farber Cancer Institute, USA Broad Institute, USA Boston Children's Hospital
William C HahnBroad Institute, Dana-Farber Cancer Institute, Brigham and Women's Hospital and Harvard Medical School
William C HahnBroad Institute, Dana-Farber Cancer Institute, Brigham and Women's Hospital and Harvard Medical School
Stuart L SchreiberBroad Institute, Harvard University
Stuart L SchreiberBroad Institute, Harvard University
Charles W M RobertsComprehensive Cancer Center and Department of Oncology, St. Jude Children's Research Hospital
  • 1 - 25

Datasets